Publication related to RSI or an RSI staff member
Dabigatran, bleeding, and the regulators.
Authors
- Moore, Thomas J, Moore TJ, Institute for Safe Medication Practices, 200 Lakeside Drive, Suite 200, Horsham, PA 19044, USA tmoore@ismp.org.
- Cohen, Michael R, Cohen MR, Institute for Safe Medication Practices, 200 Lakeside Drive, Suite 200, Horsham, PA 19044, USA.
- Mattison, Donald R, Mattison DR, Risk Sciences International, Ottawa, ON, Canada University of Ottawa, Ottawa.
YEAR OF PUBLICATION: 2014
SOURCE: BMJ. 2014 Jul 23;349:g4517. doi: 10.1136/bmj.g4517.
JOURNAL TITLE ABBREVIATION: BMJ
JOURNAL TITLE: BMJ (Clinical research ed.)
ISSN: 1756-1833 (Electronic) 0959-8138 (Linking)
VOLUME: 349
PAGES: g4517
PLACE OF PUBLICATION: England
LANGUAGE: eng
DATE OF PUBLICATION: 2014 Jul 23
DATE OF ELECTRONIC PUBLICATION: 20140723
DATE COMPLETED: 20140904
DATE REVISED: 20220408
MESH DATE: 2014/09/05 06:00
EDAT: 2014/07/25 06:00
STATUS: MEDLINE
PUBLICATION STATUS: epublish
LOCATION IDENTIFIER: 10.1136/bmj.g4517 [doi]
OWNER: NLM
Related RSI Experts
Chief Medical Officer, Senior Vice-President
Dr. Donald Mattison joined Risk Sciences International (RSI) in 2012 as Senior Vice-President and Chief Medical Officer, bringing with him a distinguished career spanning public health, clinical medicine, toxicology, and academic leadership. His appointment significantly strengthened RSI’s capacity to deliver...